I don't think it did?
In their Feb report, they forecast: "FY20 net profit after tax now expected to be in the range of approximately $2,110 million to $2,170 million at CC representing approximately 10-13% growth over FY19."
The latest came in at: "CSL delivered another strong year, with reported net profit after tax of $2,103 million, up 17% at CC and revenue up 9%..."
Maybe people smarter than me can illuminate me, but it fell short did it not?
Also: "Net profit after tax for FY21 is anticipated to be in the range of approximately $2,100 million to $2,265 million at constant currency."
So there is a risk that NPAT can be fairly flat this year...
Seems weak.
- Forums
- ASX - By Stock
- CSL
- Ann: CSL Results Announcement
Ann: CSL Results Announcement, page-4
-
-
- There are more pages in this discussion • 118 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$294.13 |
Change
-0.870(0.29%) |
Mkt cap ! $142.4B |
Open | High | Low | Value | Volume |
$295.01 | $296.50 | $293.51 | $164.4M | 558.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 136 | $294.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$294.13 | 250 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 136 | 294.100 |
1 | 1274 | 293.860 |
1 | 34 | 293.850 |
1 | 1274 | 293.700 |
1 | 1013 | 293.620 |
Price($) | Vol. | No. |
---|---|---|
294.170 | 949 | 1 |
294.190 | 750 | 1 |
294.240 | 594 | 1 |
294.270 | 46 | 1 |
294.280 | 875 | 1 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online